2-minute overview
What is FasciaClinics?
The Problem
Medicine Divided the Body. Nobody Sees the Whole.
Modern medicine has fragmented the body into specialities — orthopaedics, neurology, rheumatology, physiotherapy. Each specialist owns a part. Nobody owns the connective system that ties everything together.
Fascia — the connective tissue network running through the entire body — is the missing anatomical link. Conditions like Frozen Shoulder, chronic tension, and restricted mobility often originate here. Patients cycle through specialists indefinitely. Our pilot study on Frozen Shoulder shows measurably improved functional outcomes after fascia-based treatment.
"Stefan Sallerfors, our Chairman and radiologist with insurance medicine background, confirmed immediately: this is exactly the problem the insurance industry needs solved."
— Axel Bohlin, CSO
Multiple International Awards
German Design Award 2020 · Good Design Award 2018
The Solution
The First Scalable System for Fascia-Based Care
FasciaClinics combines proprietary technology, standardised treatment protocols, and a franchise model to make fascia-based care reproducible, trainable, and scalable — for the first time in history.
Atlasbalans Technology
Patented mechanism. German Design Award 2020. Good Design Award 2018. The only device of its kind — reproducible outcomes, trainable in weeks.
Standardised Protocol
Treatment outcomes are reproducible across all clinics. This is what makes franchise possible at scale.
Clinic-in-a-Box
Modular unit. Deployable in hotels, gyms, spas, airports. Designed for quality-assured autonomous operations from day one.
AI-Driven Knowledge Platform
Fascia Guide: 250+ hours of expert podcast content. Research Database: 5,000+ curated articles. Each new therapist strengthens the network.
Market Opportunity
A Blue Ocean in a €5.5 Trillion Market
Fascia is scientifically validated but commercially underdeveloped. Medicine has divided the body into specialities — no one owns the whole. FasciaClinics is the category creator.
TAM
€5.5T
Global wellness market (GWI 2024)
Growing ~10% annually
SAM
€180B
Therapeutic bodywork, rehabilitation, sports recovery
Addressable via clinic network
SOM
€2.4B
500 clinics × €4.8M average revenue
10-year expansion horizon
The Sweden Proof
Sweden is one of the world's most competitive markets for new concepts — not because Swedes are slow to adopt, but because they adopt everything fast. The market is saturated with trends. Spotify, Klarna, King (Candy Crush), and Mojang (Minecraft) all proved their model here before going global. Swedes were famously sceptical about gambling — today Sweden is among the world's most active gaming markets. FasciaClinics has done the same — 16 years, 100,000+ treatments, profitable franchise, without external capital until now. If it survives Sweden, it scales everywhere.
Business Model
Revenue Streams
FasciaClinics earns on every treatment performed anywhere in the world — and on every new market that opens.
Royalty per Treatment
Active nowA percentage of every treatment performed across all active clinics — globally. As the network grows, so does the royalty base. Long-term, this becomes a recurring income stream from every fascia treatment delivered worldwide.
Unit Startup Fee
Per new unitEach new clinic pays a startup fee to access the FasciaClinics system — training, protocols, technology, brand. Every new unit that opens generates an upfront revenue event for the franchisor.
Master Franchise License
Per new marketWhen a partner acquires rights to a country or region — for example, the Netherlands or a part of Germany — they pay an upfront license fee. This is the highest-margin revenue event in the model.
Clinic Formats
Entry-level clinic. Single-session treatments. Broad consumer audience. Rapid break-even.
Multi-session treatment programmes. Higher average transaction value. Targets chronic conditions and performance recovery.
Premium full-service clinic. Combines all treatment modalities. Serves as market anchor and brand showcase.
Unit Economics — Per Clinic
Annual Revenue
SEK 1.5–2.5M
Time to autonomous ops
1–2 months (top clinics)
Franchisee ROI
12–18 months
Capital to open
SEK 400–600K
Traction & Proof Points
100,000+ Treatments. 16 Years. Built on Community Capital.
FasciaClinics raised SEK 12M through crowdfunding — with approximately 500 external shareholders now owning ~10% of the company. For that capital, we built a complete, internationally scalable franchise system.
Competitive Position
16 Years Ahead. Structurally Defensible.
Individual competitors may have one element. None have all four moats. The combination takes a decade to replicate.
◆
Knowledge Moat
16 years of accumulated clinical knowledge. 100,000+ treatments. Proprietary protocols refined across dozens of clinics, built with hundreds of experts. No competitor can replicate this without a decade of operations.
◆
Technology Moat
Atlasbalans: patented mechanism, German Design Award 2020, Good Design Award 2018. The only device of its kind. Fascia Guide — 250+ hours of expert podcast content. Research Database — 5,000+ curated scientific articles.
◆
Network Moat
500+ certified specialists across Sweden. A franchise system with standardised onboarding. Each new clinic strengthens the network, not just the P&L.
◆
Brand & Science Moat
Swedish Fascia Convention (250+ attendees, 20+ countries). Direct collaboration with leading fascia researchers globally. Nature-published research validates the anatomical foundation.
Expansion Strategy
Anchor Markets. Proven Model. Capital-Efficient Scale.
Each market entry follows the same playbook: identify a master franchisee with local distribution, deploy the standardised system, achieve quality-assured autonomous operations, then scale.
Phase 1
2026
Japan + USA Preparation
LLC formation underway. Atleta partnership in negotiation (master franchisee candidate). Government alignment via Nakai-san (former Diet member, under negotiation). Structured Silence retreat September 2026. USA market research and B2B wellness channel development.
Phase 2
2027
USA Anchor Market
B2B wellness and corporate health channel activation. Treatment-in-a-Box rollout in hotel/spa/corporate wellness. Target: 20 clinics across 5 anchor cities.
Phase 3
2028–2029
European Expansion
Master franchise agreements in Germany, Netherlands, UK. Knowledge platform AI-driven, generating recurring SaaS revenue. Network of 100+ clinics generating royalty income globally.
Japan — Active 2026
LLC formation underway
Atleta partnership — master franchisee candidate
Under negotiation
Government alignment via Nakai-san (former Diet member)
Under negotiation
Structured Silence retreat — September 2026
¥13 trillion healthcare market
Clinic-in-a-Box — modular, deployable, quality-assured
The Team
The Team That Built This From Zero
Board of Directors
Stefan Sallerfors
Chairman
Medical doctor with background in radiology and insurance medicine. 12 years as Chairman of Spotlight Group. Confirms B2B insurance logic: FasciaClinics addresses root-cause conditions that cost insurers billions annually.
Johan Engström
Board Member
Former CEO of Fastighetsbyrån. Deep experience in franchise operations and scaling. His core insight: the more systematised the experience, the easier to recruit, onboard, and quality-assure franchisees.
Lena Bohlin
Board Member
30 years of experience in financial management from Umeå University. Ensures capital discipline and operational integrity across the group.
Fredrik Ekblom
Board Member
Strategic advisor and investor with experience from growth companies. Finance professional with background from Nordnet and Swedbank.
Thomas Strömberg
Board Member
Former Deputy CEO at Deloitte. Broad experience in audit, growth, and corporate governance.
In-depth — 22 minutes
Get to Know the People Behind the Concept
Axel and Ivar discuss the business model, expansion strategy, and why they're raising capital now — in an unfiltered conversation.
Financial Snapshot
Track Record & Forecast
FasciaClinics has grown nearly 10× in revenue since 2022 with positive EBITDA every year. Forecasts from 2026 include first international master franchise revenue.
2022
$0.8M
Actual revenue
2023
$1.6M
Actual revenue
+111%
2024
$2.0M
Actual revenue
+22%
2025P
$2.8M
Projected revenue
+40%
2026P
$8.9M
Total incl. intl.
+154%
2029P
$36M
Combined target
Revenue ($M) — Sweden + International
$0.8M
2022
$1.6M
2023
$2M
2024
$2.8M
2025P
$8.9M
2026P
$14.5M
2027P
$23M
2028P
$36M
2029P
Sweden
International
Projected
FasciaClinics Sweden — Revenue & Clinic Count
| 2022 | 2023 | 2024 | 2025P | 2026P | 2027P | 2028P | 2029P | |
|---|---|---|---|---|---|---|---|---|
| Revenue ($M) | 0.8 | 1.6 | 2.0 | 2.8 | 7.1 | 12.0 | 18.0 | 26.0 |
| Growth % | — | +111% | +22% | +40% | +154% | +69% | +50% | +44% |
| Franchise clinics | 5 | 12 | 3 | 17 | 17 | 22 | 28 | 35 |
| Concept partners | — | — | — | — | 10 | 20 | 35 | 50 |
Combined Revenue — National + International ($M)
| 2025P | 2026P | 2027P | 2028P | 2029P | |
|---|---|---|---|---|---|
| Sweden revenue ($M) | 2.8 | 7.1 | 12.0 | 18.0 | 26.0 |
| Intl. revenue ($M) | — | 1.8 | 2.5 | 5.0 | 10.0 |
| Intl. clinics | — | 8 | 25 | 60 | 120 |
| Total revenue ($M) | 2.8 | 8.9 | 14.5 | 23.0 | 36.0 |
What the Numbers Don't Show Yet
The current revenue base reflects Sweden only. The first master franchise agreement — covering a country or region — generates an upfront license fee plus ongoing royalties from every treatment performed in that market. As the network scales to 100+ clinics globally, the royalty base compounds. The model is designed so that central costs grow slower than revenue at every stage.
The Opportunity
Why This. Why Now.
FasciaClinics has spent 16 years proving the model without institutional capital. The crowdfunding rounds validated community demand — nearly 500 investors believed in this before the international story was written. The next phase is about scale.
We are not looking for passive capital. We are looking for partners who understand what category creation looks like — and who want to be part of building the Anytime Fitness of fascia-based care.
Use of Funds
Production scaling (Atlasbalans) + international market entry + franchise system infrastructure
Round Type
Angel investors, family offices, institutional
Stage
Post-revenue, pre-scale
Comparables
Anytime Fitness (franchise), Therabody (device), Mindbody (platform)
Return Thesis
Revenue Path
100+ clinics × franchise royalties per treatment + unit startup fees + master franchise license fees per new market = multiple revenue streams scaling simultaneously.
Exit Horizon
2029 target. Strategic acquirer (global wellness group, insurance company, PE roll-up) or listing on Nordic exchange.
Risk Mitigation
Profitable franchise model already proven. Franchisee bears operational risk. Asset-light model. No single point of failure.
Downside Protection
Even at conservative growth, every active clinic generates ongoing royalty income. The royalty base is recurring and compounds with each new unit — regardless of machine sales or platform revenue.